Pharmerica (PMC) Tops Q1 EPS by 2c

Pharmerica (NYSE: PMC) reported Q1 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $524.5 million versus the consensus estimate of $509.45 million.

Pharmerica reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Unifi, Inc. (UFI) Misses Q4 EPS by 11c
• John B. Sanfilippo & Son (JBSS) Misses Q4 EPS by 59c